A Combined Fabrication and Instrumentation Platform for Sample Preparation

While potentially powerful, access to molecular diagnostics is substantially limited in the developing world. Here we present an approach to reduced cost molecular diagnostic instrumentation that has the potential to empower developing world communities by reducing costs through streamlining the sample preparation process. In addition, this instrument is capable of producing its own consumable devices on demand, reducing reliance on assay suppliers. Furthermore, this instrument is designed with an “open” architecture, allowing users to visually observe the assay process and make modifications as necessary (as opposed to traditional “black box” systems). This open environment enables integration of microfluidic fabrication and viral RNA purification onto an easy-to-use modular system via the use of interchangeable trays. Here we employ this system to develop a protocol to fabricate microfluidic devices and then use these devices to isolate viral RNA from serum for the measurement of human immunodeficiency virus (HIV) viral load. Results obtained from this method show significantly reduced error compared with similar nonautomated sample preparation processes.

[1]  Albert W Jekelis Increased instrument intelligence--can it reduce laboratory error? , 2005, Biomedical instrumentation & technology.

[2]  Xavier Anglaret,et al.  Transfer and Evaluation of an Automated, Low-Cost Real-Time Reverse Transcription-PCR Test for Diagnosis and Monitoring of Human Immunodeficiency Virus Type 1 Infection in a West African Resource-Limited Setting , 2005, Journal of Clinical Microbiology.

[3]  David J Beebe,et al.  One-step purification of nucleic acid for gene expression analysis via Immiscible Filtration Assisted by Surface Tension (IFAST). , 2011, Lab on a chip.

[4]  J. Pawliszyn,et al.  Automation of solid-phase microextraction in high-throughput format and applications to drug analysis. , 2008, Analytical chemistry.

[5]  Chunsun Zhang,et al.  PCR microfluidic devices for DNA amplification. , 2006, Biotechnology advances.

[6]  P. Weidle,et al.  Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance , 2002, The Lancet.

[7]  Avettand‐Fènoël Véronique,et al.  LTR real‐time PCR for HIV‐1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01) , 2009 .

[8]  P. Yager,et al.  Point-of-care diagnostics for global health. , 2008, Annual review of biomedical engineering.

[9]  Yoko Shimada,et al.  Challenges in implementing CD4 testing in resource‐limited settings , 2008, Cytometry. Part B, Clinical cytometry.

[10]  Janusz Pawliszyn,et al.  Solid-Phase Microextraction. A Solvent-Free Alternative for Sample Preparation , 1994 .

[11]  S. Hammer,et al.  The Relation between Baseline HIV Drug Resistance and Response to Antiretroviral Therapy: Re-Analysis of Retrospective and Prospective Studies Using a Standardized Data Analysis Plan , 2000, Antiviral therapy.

[12]  David J Beebe,et al.  The VerIFAST: an integrated method for cell isolation and extracellular/intracellular staining. , 2013, Lab on a chip.

[13]  D. Beebe,et al.  Automated Operation of Immiscible Filtration Assisted by Surface Tension (IFAST) Arrays for Streamlined Analyte Isolation , 2013, Journal of laboratory automation.

[14]  R. Peeling,et al.  Diagnostic tests for infectious diseases in the developing world: two sides of the coin. , 2007, Transactions of the Royal Society of Tropical Medicine and Hygiene.